Winton Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $789K | Buy |
+2,040
| New | +$757K | 0.03% | 564 |
|
|
2025
Q2 | – | Sell |
-4,800
| Closed | -$2.09M | – | 871 |
|
|
2025
Q1 | $2.09M | Sell |
4,800
-9,016
| -65% | -$3.62M | 0.13% | 179 |
|
|
2024
Q4 | $5.1M | Buy |
+13,816
| New | +$5.78M | 0.34% | 87 |
|
|
2024
Q3 | – | Sell |
-6,771
| Closed | -$3.67M | – | 665 |
|
|
2024
Q2 | $3.67M | Buy |
+6,771
| New | +$3.58M | 0.25% | 80 |
|
|
2023
Q2 | – | Sell |
-1,396
| Closed | -$642K | – | 873 |
|
|
2023
Q1 | $642K | Sell |
1,396
-6,138
| -81% | -$2.92M | 0.04% | 602 |
|
|
2022
Q4 | $3.86M | Buy |
7,534
+388
| +5% | +$197K | 0.25% | 61 |
|
|
2022
Q3 | $3.25M | Buy |
7,146
+280
| +4% | +$134K | 0.21% | 92 |
|
|
2022
Q2 | $3.31M | Buy |
6,866
+1,917
| +39% | +$948K | 0.18% | 140 |
|
|
2022
Q1 | $2.43M | Sell |
4,949
-1,901
| -28% | -$869K | 0.13% | 204 |
|
|
2021
Q4 | $3.17M | Buy |
6,850
+4,877
| +247% | +$2.05M | 0.19% | 101 |
|
|
2021
Q3 | $736K | Sell |
1,973
-1,424
| -42% | -$541K | 0.04% | 663 |
|
|
2021
Q2 | $1.3M | Buy |
3,397
+2,252
| +197% | +$861K | 0.07% | 385 |
|
|
2021
Q1 | $411K | Buy |
1,145
+348
| +44% | +$112K | 0.02% | 980 |
|
|
2020
Q4 | $256K | Sell |
797
-1,718
| -68% | -$527K | 0.02% | 1105 |
|
|
2020
Q3 | $676K | Sell |
2,515
-21,574
| -90% | -$5.8M | 0.02% | 984 |
|
|
2020
Q2 | $6.33M | Sell |
24,089
-7,534
| -24% | -$2.01M | 0.16% | 135 |
|
|
2020
Q1 | $7.18M | Buy |
31,623
+7,617
| +32% | +$2.08M | 0.19% | 137 |
|
|
2019
Q4 | $7.25M | Buy |
24,006
+21,746
| +962% | +$5.98M | 0.1% | 343 |
|
|
2019
Q3 | $543K | Sell |
2,260
-11,556
| -84% | -$3.17M | 0.01% | 1058 |
|
|
2019
Q2 | $3.9M | Sell |
13,816
-86,111
| -86% | -$23.5M | 0.08% | 230 |
|
|
2019
Q1 | $28.7M | Buy |
99,927
+19,928
| +25% | +$5.76M | 0.58% | 43 |
|
|
2018
Q4 | $21M | Sell |
79,999
-292
| -0.4% | -$80.3K | 0.45% | 54 |
|
|
2018
Q3 | $22M | Buy |
80,291
+46,590
| +138% | +$12.1M | 0.46% | 45 |
|
|
2018
Q2 | $8.02M | Sell |
33,701
-57,125
| -63% | -$13.2M | 0.21% | 190 |
|
|
2018
Q1 | $20M | Sell |
90,826
-232
| -0.3% | -$54.5K | 0.56% | 30 |
|
|
2017
Q4 | $20.5M | Sell |
91,058
-7,824
| -8% | -$1.67M | 0.59% | 25 |
|
|
2017
Q3 | $18.8M | Sell |
98,882
-52,530
| -35% | -$10M | 0.6% | 38 |
|
|
2017
Q2 | $28.5M | Sell |
151,412
-102,131
| -40% | -$18.4M | 0.84% | 18 |
|
|
2017
Q1 | $41.9M | Buy |
253,543
+16,648
| +7% | +$2.65M | 1.14% | 14 |
|
|
2016
Q4 | $34.1M | Sell |
236,895
-103,760
| -30% | -$13.9M | 1.12% | 14 |
|
|
2016
Q3 | $42.7M | Sell |
340,655
-32,661
| -9% | -$4.22M | 0.73% | 31 |
|
|
2016
Q2 | $49M | Sell |
373,316
-103,043
| -22% | -$14.1M | 0.81% | 25 |
|
|
2016
Q1 | $66.2M | Sell |
476,359
-176,389
| -27% | -$23.6M | 0.72% | 28 |
|
|
2015
Q4 | $91M | Buy |
652,748
+4,455
| +0.7% | +$614K | 0.81% | 22 |
|
|
2015
Q3 | $90.8M | Buy |
648,293
+95,970
| +17% | +$14.4M | 0.72% | 19 |
|
|
2015
Q2 | $90.7M | Sell |
552,323
-315,179
| -36% | -$50.4M | 0.83% | 19 |
|
|
2015
Q1 | $134M | Buy |
867,502
+347,345
| +67% | +$49.5M | 1.07% | 3 |
|
|
2014
Q4 | $65.4M | Sell |
520,157
-371,537
| -42% | -$45.9M | 0.81% | 10 |
|
|
2014
Q3 | $107M | Sell |
891,694
-146,543
| -14% | -$16.8M | 0.76% | 5 |
|
|
2014
Q2 | $112M | Buy |
+1,038,237
| New | +$107M | 0.76% | 5 |
|
Other funds holding ELV
Winton Group's ELV Position: Q2 2026 in Review
Winton Group opened a new position in Elevance Health (ELV) in Q2 2026: 2,040 shares worth $789K. The stake represents 0.03% of the portfolio and ranks #564 among its holdings. This is a return to the name: Winton Group previously reported a position in ELV as recently as Q1 2025.
Winton Group first reported a position in ELV in Q2 2014 and has held it in 40 quarters since. The position peaked at $134M in Q1 2015. 972 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Winton Group held 2,040 shares of Elevance Health worth $789K as of Q2 2026.
- Elevance Health was a new Winton Group position in Q2 2026.
- Elevance Health made up 0.03% of Winton Group's portfolio in Q2 2026, its #564 holding.
- Winton Group first reported a position in Elevance Health in Q2 2014 and has held it in 40 quarters since.
- Winton Group's Elevance Health position peaked at $134M in Q1 2015.
- 972 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.